thoroughly < those < though

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by those

Number of relevant bibliographic references: 108.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000023 (2021)	Consuelo Luna-Mu Oz [Pérou] ; Giuliana Reyes-Florian [Pérou] ; Martin Seminario-Aliaga [Pérou] ; Angie Stapleton-Herbozo [Pérou] ; Lucy E. Correa-L Pez [Pérou] ; Dante M. Qui Ones-Laveriano [Pérou]	[Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital].
000056 (2021)	Jessica S C. Leung [Hong Kong] ; Maurice M W. Cheng [Nouvelle-Zélande]	Trust in the time of corona: epistemic practice beyond hard evidence.
000083 (2021)	Nurdan Kokturk [Turquie] ; Cenk Babayigit [Turquie] ; Seval Kul [Turquie] ; Pelin Duru Cetinkaya [Turquie] ; Sibel Atis Nayci [Turquie] ; Serap Argun Baris [Turquie] ; Oguz Karcioglu [Turquie] ; Pinar Aysert [Turquie] ; Ilim Irmak [Turquie] ; Aycan Akbas Yuksel [Turquie] ; Yonca Sekibag [Turquie] ; Oya Baydar Toprak [Turquie] ; Emel Azak [Oman] ; Sait Mulamahmutoglu [Turquie] ; Caglar Cuhadaroglu [Turquie] ; Aslihan Demirel [Turquie] ; Bugra Kerget [Turquie] ; Burcu Baran Ketencioglu [Turquie] ; Hasan Selcuk Ozger [Turquie] ; Gulcihan Ozkan [Turquie] ; Zeynep Ture [Turquie] ; Begum Ergan [Turquie] ; Vildan Avkan Oguz [Turquie] ; Oguz Kilinc [Turquie] ; Merve Ercelik [Turquie] ; Tansu Ulukavak Ciftci [Turquie] ; Ozlem Alici [Turquie] ; Esra Nurlu Temel [Turquie] ; Ozlem Ataoglu [Turquie] ; Asena Aydin [Turquie] ; Dilek Cetiner Bahcetepe [Turquie] ; Yusuf Taha Gullu [Turquie] ; Fusun Fakili [Turquie] ; Figen Deveci [Turquie] ; Neslihan Kose [Turquie] ; Muge Meltem Tor [Turquie] ; Gulsah Gunluoglu [Turquie] ; Sedat Altin [Turquie] ; Teyfik Turgut [Turquie] ; Tibel Tuna [Turquie] ; Onder Ozturk [Turquie] ; Oner Dikensoy [Turquie] ; Pinar Yildiz Gulhan [Turquie] ; Ilknur Basyigit [Turquie] ; Hasim Boyaci [Turquie] ; I Kivilcim Oguzulgen [Turquie] ; Sermin Borekci [Turquie] ; Bilun Gemicioglu [Turquie] ; Firat Bayraktar [Turquie] ; Osman Elbek [Turquie] ; Ismail Hanta [Turquie] ; Hacer Kuzu Okur [Turquie] ; Gulseren Sagcan [Turquie] ; Oguz Uzun [Turquie] ; Metin Akgun [Turquie] ; Goksel Altinisik [Turquie] ; Berna Dursun [Turquie] ; Ebru Cakir Edis [Turquie] ; Erkmen Gulhan [Turquie] ; Fusun Oner Eyuboglu [Turquie] ; Okkes Gultekin [Turquie] ; Yavuz Havlucu [Turquie] ; Metin Ozkan [Turquie] ; Aysin Sakar Coskun [Turquie] ; Abdullah Sayiner [Turquie] ; Ali Fuat Kalyoncu [Turquie] ; Oya Itil [Turquie] ; Hasan Bayram [Turquie]	The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients.
000105 (2021)	Nour K. Younis [Liban] ; Rana O. Zareef [Liban] ; Mohammad Ali N. Maktabi [Liban] ; Rami Mahfouz [Liban]	The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.
000109 (2021)	Hailey Olds [États-Unis] ; Jesse Liu [États-Unis] ; Kevin Luk [États-Unis] ; Henry W. Lim [États-Unis] ; David Ozog [États-Unis] ; Pranita V. Rambhatla [États-Unis]	Telogen effluvium associated with COVID-19 infection.
000133 (2021)	Isidro García-Meni O [Espagne] ; Lorena Forcelledo [Espagne] ; Yaiza Rosete [Espagne] ; Emilio García-Prieto [Espagne] ; Dolores Escudero [Espagne] ; Javier Fernández [Espagne]	Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm.
000158 (2021)	Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte]	Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
000175 (2021)	Okechukwu S. Ogah [Nigeria] ; Ejiroghene M. Umuerri ; Adewole Adebiyi [Nigeria] ; Olanike A. Orimolade [Nigeria] ; Mahmoud U. Sani ; Dike B. Ojji ; Amam C. Mbakwem ; Simon Stewart ; Karen Sliwa	SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications.
000183 (2021)	Byung Jin Choi [Corée du Sud] ; Yeryung Koo [Corée du Sud] ; Tae Young Kim [Corée du Sud] ; Wou Young Chung [Corée du Sud] ; Yun Jung Jung [Corée du Sud] ; Ji Eun Park [Corée du Sud] ; Hong-Seok Lim [Corée du Sud] ; Bumhee Park [Corée du Sud] ; Dukyong Yoon [Corée du Sud]	Risk of QT prolongation through drug interactions between hydroxychloroquine and concomitant drugs prescribed in real world practice.
000189 (2021)	Kirill Alekseyev [États-Unis] ; Lidiya Didenko [États-Unis] ; Bilal Chaudhry [États-Unis]	Rhinocerebral Mucormycosis and COVID-19 Pneumonia.
000215 (2021)	Alexandre O. Gérard [France] ; Audrey Laurain [France] ; Audrey Fresse [France] ; Nadège Parassol [France] ; Marine Muzzone [France] ; Fanny Rocher [France] ; Vincent L M. Esnault [France] ; Milou-Daniel Drici [France]	Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database.
000270 (2021)	Enrico Scala [Italie] ; Luca Fania [Italie] ; Filippo Bernardini [Italie] ; Rodolfo Calarco [Italie] ; Sabrina Chiloiro [Italie] ; Cristiana Di Campli [Italie] ; Sabrina Erculei [Italie] ; Mauro Giani [Italie] ; Marzia Giordano [Italie] ; Annarita Panebianco [Italie] ; Francesca Passarelli [Italie] ; Andrea Trovè [Italie] ; Sofia Verkhovskaia [Italie] ; Giandomenico Russo [Italie] ; Antonio Sgadari [Italie] ; Biagio Didona [Italie] ; Damiano Abeni [Italie]	Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.
000272 (2021)	Tia A. Tummino ; Veronica V. Rezelj ; Benoit Fischer ; Audrey Fischer ; Matthew J. O'Meara ; Blandine Monel ; Thomas Vallet ; Ziyang Zhang ; Assaf Alon ; Henry R. O'Donnell ; Jiankun Lyu ; Heiko Schadt ; Kris M. White ; Nevan J. Krogan ; Laszlo Urban ; Kevan M. Shokat ; Andrew C. Kruse ; Adolfo García-Sastre ; Olivier Schwartz ; Francesca Moretti ; Marco Vignuzzi ; Francois Pognan ; Brian K. Shoichet	Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2.
000292 (2021)	Hesham Refaat [Égypte] ; Fatma M. Mady [Égypte] ; Hatem A. Sarhan [Égypte] ; Heba S. Rateb [Égypte] ; Eman Alaaeldin [Égypte]	Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19.
000295 (2021)	Zheng Zequn [République populaire de Chine] ; Wu Yujia [République populaire de Chine] ; Qian Dingding [République populaire de Chine] ; Lian Jiangfang [République populaire de Chine]	Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.
000299 (2021)	Marko Boban [Croatie]	Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments.
000346 (2021)	Hardeep Singh Tuli [Inde] ; Shivani Sood ; Jagjit Kaur [Australie] ; Pawan Kumar [Israël] ; Prachi Seth ; Sandeep Punia [Inde] ; Priya Yadav [Inde] ; Anil Kumar Sharma [Inde] ; Diwakar Aggarwal [Inde] ; Katrin Sak [Estonie]	Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements.
000365 (2021)	Esben B. Svenningsen [Danemark] ; Jacob Thyrsted [Danemark] ; Julia Blay-Cadanet [Danemark] ; Han Liu [Danemark] ; Shaoquan Lin [Danemark] ; Jaime Moyano-Villameriel [Danemark] ; David Olagnier [Danemark] ; Manja Idorn [Danemark] ; S Ren R. Paludan [Danemark] ; Christian K. Holm [Danemark] ; Thomas B. Poulsen [Danemark]	Ionophore antibiotic X-206 is a potent inhibitor of SARS-CoV-2 infection in vitro.
000371 (2021)	Serena Romani [France] ; Alexandre Gérard [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Élise Van-Obberghen [France] ; Joëlle Micallef [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]	Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic.
000441 (2021)	Asokan Devarajan [États-Unis] ; Marmar Vaseghi [États-Unis]	Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights.
000473 (2021)	Jihad G. Youssef [États-Unis] ; Faisal Zahiruddin [États-Unis] ; George Youssef [États-Unis] ; Sriram Padmanabhan [États-Unis] ; Joe Ensor [États-Unis] ; Sai Ravi Pingali [États-Unis] ; Youli Zu [États-Unis] ; Sandeep Sahay [États-Unis] ; Swaminathan P. Iyer [États-Unis]	G6PD deficiency and severity of COVID19 pneumonia and acute respiratory distress syndrome: tip of the iceberg?

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "those" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "those" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    those
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021